Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper Rossing

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Kidney International|August 18, 2005
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuriaKasper Rossing, Katrine J Schjoedt, Berit R Jensen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 9, 2013
Serial measurements of high-sensitivity cardiac troponin T after exercise stress test in stable coronary artery diseaseAnna Axelsson, Martin Huth Ruwald, Morten Dalsgaard, et al.
Clinical Transplantation|October 17, 2020
Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipientsLaerke Marie Nelson, Kasper Rossing, Nikolaj Ihlemann, et al.
Kidney International|October 2, 2004
Progression of nephropathy in type 2 diabetic patientsKasper Rossing, Per K Christensen, Peter Hovind, et al.
ESC Heart Failure|February 28, 2023
Prevalence of heart failure phenotypes and current use of therapies in primary care: results from a nationwide studyJesper Jensen, Mikael Kjaer Poulsen, Per Warrer Petersen, et al.
Proteomics. Clinical Applications|December 8, 2010
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapyKasper Rossing, Harald Mischak, Peter Rossing, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 11, 2022
Oxygen Uptake During Activities of Daily Life in Patients Treated With a Left Ventricular Assist DeviceKiran K Mirza, Thomas Bonne, Nikolai B Nordsborg, et al.
Biomarkers in Medicine|July 31, 2018
Copeptin levels and invasive hemodynamics in patients with advanced heart failureLouise Balling, Jens Peter Goetze, Mette Holme Jung, et al.
Diabetes Care|March 1, 2003
Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria studyKasper Rossing, Per K Christensen, Steen Andersen, et al.
Amino Acids|March 9, 2011
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuriaNaila Rabbani, Antonysunil Adaikalakoteswari, Kasper Rossing, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Kidney International|August 18, 2005
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuriaKasper Rossing, Katrine J Schjoedt, Berit R Jensen, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 9, 2013
Serial measurements of high-sensitivity cardiac troponin T after exercise stress test in stable coronary artery diseaseAnna Axelsson, Martin Huth Ruwald, Morten Dalsgaard, et al.
Clinical Transplantation|October 17, 2020
Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipientsLaerke Marie Nelson, Kasper Rossing, Nikolaj Ihlemann, et al.
Kidney International|October 2, 2004
Progression of nephropathy in type 2 diabetic patientsKasper Rossing, Per K Christensen, Peter Hovind, et al.
ESC Heart Failure|February 28, 2023
Prevalence of heart failure phenotypes and current use of therapies in primary care: results from a nationwide studyJesper Jensen, Mikael Kjaer Poulsen, Per Warrer Petersen, et al.
Proteomics. Clinical Applications|December 8, 2010
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapyKasper Rossing, Harald Mischak, Peter Rossing, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 11, 2022
Oxygen Uptake During Activities of Daily Life in Patients Treated With a Left Ventricular Assist DeviceKiran K Mirza, Thomas Bonne, Nikolai B Nordsborg, et al.
Biomarkers in Medicine|July 31, 2018
Copeptin levels and invasive hemodynamics in patients with advanced heart failureLouise Balling, Jens Peter Goetze, Mette Holme Jung, et al.
Diabetes Care|March 1, 2003
Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria studyKasper Rossing, Per K Christensen, Steen Andersen, et al.
Amino Acids|March 9, 2011
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuriaNaila Rabbani, Antonysunil Adaikalakoteswari, Kasper Rossing, et al.
Pageof 10